Literature DB >> 16638885

Review: longer duration of untreated psychosis is associated with worse outcome in people with first episode psychosis.

Diana O Perkins1.   

Abstract

Entities:  

Year:  2006        PMID： 16638885     DOI： 10.1136/ebmh.9.2.36

Source DB:  PubMed          Journal:  Evid Based Ment Health        ISSN： 1362-0347


× No keyword cloud information.
  5 in total

1.  Detection, Assessment, and Management of Schizophrenia in an Andean Population of South America: Parkinsonism Testing and Transcranial Ultrasound as Preventive Tools.

Authors:  Mara Balda; Maria Calvó; Eduardo Padilla; Gonzalo Guerrero; Juan Molina; Nestor V Florenzano; Danielle Kamis; Javier I Escobar; C Robert Cloninger; Gabriel de Erausquin
Journal:  Focus (Am Psychiatr Publ)       Date:  2015

2.  The efficacy of targeted health agents education to reduce the duration of untreated psychosis in a rural population.

Authors:  Eduardo Padilla; Juan Molina; Danielle Kamis; Maria Calvo; Lee Stratton; Sergio Strejilevich; Gabriela Gonzalez Aleman; Gonzalo Guerrero; Mercedes Bourdieu; Horacio A Conesa; Javier I Escobar; Gabriel A de Erausquin
Journal:  Schizophr Res       Date:  2014-11-28       Impact factor: 4.939

3.  Prodromal research: Public health initiatives for prevention of schizophrenia.

Authors:  Amresh Shrivastava
Journal:  Indian J Psychiatry       Date:  2010-01       Impact factor: 1.759

4.  Duration of Untreated Psychosis Correlates With Brain Connectivity and Morphology in Medication-Naïve Patients With First-Episode Psychosis.

Authors:  Jose O Maximo; Eric A Nelson; William P Armstrong; Nina V Kraguljac; Adrienne C Lahti
Journal:  Biol Psychiatry Cogn Neurosci Neuroimaging       Date:  2019-11-09

5.  Hippocampal glutamate and hippocampus subfield volumes in antipsychotic-naive first episode psychosis subjects and relationships to duration of untreated psychosis.

Authors:  Frédéric Briend; Eric A Nelson; Omar Maximo; William P Armstrong; Nina V Kraguljac; Adrienne C Lahti
Journal:  Transl Psychiatry       Date:  2020-05-12       Impact factor: 6.222
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.